Details for New Drug Application (NDA): 050566
NDA 050566 describes ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. Additional details are available on the ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.
The generic ingredient in ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cefazolin sodium. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
The generic ingredient in ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cefazolin sodium. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Summary for 050566
| Tradename: | ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
| Applicant: | Baxter Hlthcare |
| Ingredient: | cefazolin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050566
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
| Approval Date: | Jun 8, 1983 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 20MG BASE/ML | ||||
| Approval Date: | Jun 8, 1983 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
| Approval Date: | Jun 8, 1983 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
